Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Automatic substantia nigra segmentation in neuromelanin-sensitive MRI by deep neural network in patients with prodromal and manifest synucleinopathy.
Krupička R, Mareček S, Malá C, Lang M, Klempíř O, Duspivová T, Široká R, Jarošíková T, Keller J, Šonka K, Růžička E, Dušek P. Krupička R, et al. Among authors: mala c. Physiol Res. 2019 Dec 30;68(Suppl 4):S453-S458. doi: 10.33549/physiolres.934380. Physiol Res. 2019. PMID: 32118476 Free article. Clinical Trial.
Lower Limb Exoskeleton Sensors: State-of-the-Art.
Neťuková S, Bejtic M, Malá C, Horáková L, Kutílek P, Kauler J, Krupička R. Neťuková S, et al. Among authors: mala c. Sensors (Basel). 2022 Nov 23;22(23):9091. doi: 10.3390/s22239091. Sensors (Basel). 2022. PMID: 36501804 Free PMC article. Review.
First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery.
Pfeiffer N, Voykov B, Renieri G, Bell K, Richter P, Weigel M, Thieme H, Wilhelm B, Lorenz K, Feindor M, Wosikowski K, Janicot M, Päckert D, Römmich R, Mala C, Fettes P, Leo E. Pfeiffer N, et al. Among authors: mala c. PLoS One. 2017 Nov 30;12(11):e0188899. doi: 10.1371/journal.pone.0188899. eCollection 2017. PLoS One. 2017. PMID: 29190672 Free PMC article. Clinical Trial.
A phase I pharmacokinetic and pharmacodynamic study of the oral mitogen-activated protein kinase kinase (MEK) inhibitor, WX-554, in patients with advanced solid tumours.
Jamieson D, Griffin MJ, Sludden J, Drew Y, Cresti N, Swales K, Merriman M, Allen R, Bevan P, Buerkle M, Mala C, Coyle V, Rodgers L, Dean E, Greystoke A, Banerji U, Wilson RH, Evans TR, Anthoney A, Ranson M, Boddy AV, Plummer R. Jamieson D, et al. Among authors: mala c. Eur J Cancer. 2016 Nov;68:1-10. doi: 10.1016/j.ejca.2016.08.026. Epub 2016 Sep 28. Eur J Cancer. 2016. PMID: 27693888 Free article. Clinical Trial.
Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer.
Heinemann V, Ebert MP, Laubender RP, Bevan P, Mala C, Boeck S. Heinemann V, et al. Among authors: mala c. Br J Cancer. 2013 Mar 5;108(4):766-70. doi: 10.1038/bjc.2013.62. Epub 2013 Feb 14. Br J Cancer. 2013. PMID: 23412098 Free PMC article. Clinical Trial.
22 results